Rising Cancer Rates Fuel Growth In Transfection Reagents And Equipment Market: A Key Catalyst Accelerating Transfection Reagents And Equipment Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Transfection Reagents And Equipment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the market size for transfection reagents and equipment has seen significant expansion. Its growth is projected to continue, starting from a valuation of $1.58 billion in 2024 and eventually reaching $1.75 billion in 2025, with a compound annual growth rate (CAGR) of 10.7%. A range of factors has contributed to this historical growth spurt, including the demand for biomedical research, advances in pharmaceutical development, the rise of biotechnology applications, the contributions of academic and research institutions, and break-through advancements in genetic engineering.

Transfection Reagents And Equipment Market Size Forecast: What's the Projected Valuation by 2029?
There is an anticipation for a swift expansion in the transfection reagents and equipment market over the forthcoming years. It's predicted to reach "$2.69 billion by 2029 at a compound annual growth rate (CAGR) of 11.3%. This expansion through the prognosis period is credited to progress in gene therapy, heightened needs for bioproduction, the emergence of cell-based therapies, personalized medicine research & development, and international collaborations. Within the prognosis period, key trends to look out for include a spotlight on primary cell transfection, a switch towards electroporation techniques, the integration of nanotechnology into transfection, growing demand for animal-free transfection reagents, and the automation and high-throughput of transfection systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

What Are the Drivers Transforming the Transfection Reagents And Equipment Market?
The increasing global count of individuals with cancer is predicted to drive the expansion of the transfection reagents and equipment market. Cancer comprises a series of illnesses where cells multiply abnormally and without control. Transfection reagents, often employed in cancer research, are used to introduce external genetic material like plasmid DNA or RNA molecules. This helps researchers to unravel different facets of cancer biology, such as gene expression studies, gene muting, drug screening, and target validation. For example, the American Cancer Society, a charity organization based in the US, reported 20 million newly diagnosed cancer cases and 9.7 million fatalities in 2022. Consequently, the upsurge in global cancer patients fuels the development of the transfection reagents and equipment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp

What Long-Term Trends Will Define the Future of the Transfection Reagents And Equipment Market?
In the transfection reagents and equipment market, a significant trend emerging is product innovation. Many leading companies are prioritizing the creation of innovative products to maintain their market standing. Case in point, Polyplus-Transfection SA, a biotechnology firm based in France, rolled out an in vivo-jetRNA+ transfection reagent for in vivo mRNA delivery through a pre-set liposome formulation in September 2022. This advanced product is a scalable and highly effective gene delivery system that can transport mRNA to different cells and tissues. It is safe, well-received and offers massive potential for the development of novel gene therapies. Its ready-for-use design eliminates the necessity for formulation stages while its consistent liposome size facilitates mRNA concentrations of various levels over time. This product finds usage in prophylactic vaccinations, mRNA treatments such as cancer therapy and rare diseases treatment, along with gene editing.

Which Segments in the Transfection Reagents And Equipment Market Offer the Most Profit Potential?
The transfection reagents and equipment market covered in this report is segmented -

1) By Products: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By Organism: Bacteria, Mammalian Cells, Fungi, Plants, Virus
4) By End User: Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs), Academia, Hospitals, Clinical Labs, Other End Users

Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems, Other Instruments
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits, Other Reagents And Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10780&type=smp

Which Firms Dominate the Transfection Reagents And Equipment Market by Market Share and Revenue in 2025?
Major companies operating in the transfection reagents and equipment market include Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., Maxcyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Sartorius AG, Takara Bio Inc., Tecan Trading AG, Polyplus-transfection SA, Sigma-Aldrich Corporation, Hoffmann-La Roche Ltd., Transfection Technologies Inc., Viromer, ABM Inc., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc., chemicell GmbH, Genlantis, Biontex Laboratories GmbH, Boca Scientific Inc., Jena Bioscience GmbH

Which Regions Offer the Highest Growth Potential in the Transfection Reagents And Equipment Market?
North America was the largest region in the transfection reagents and equipment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10780

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.